Invention Grant
- Patent Title: Saffron extract and its use for the prevention of mood disorders related to depression
-
Application No.: US16087585Application Date: 2017-04-17
-
Publication No.: US10933110B2Publication Date: 2021-03-02
- Inventor: Antonio Manuel Inarejos García , Marin Prodanov Prodanov , Amanda Rao , Jean-Marie Raymond
- Applicant: PHARMACTIVE BIOTECH PRODUCTS, S.L.
- Applicant Address: ES Madrid
- Assignee: PHARMACTIVE BIOTECH PRODUCTS, S.L.
- Current Assignee: PHARMACTIVE BIOTECH PRODUCTS, S.L.
- Current Assignee Address: ES Madrid
- Agency: Womble Bond Dickinson (US) LLP
- Priority: ESES201630491 20160418
- International Application: PCT/ES2017/070237 WO 20170417
- International Announcement: WO2017/182688 WO 20171026
- Main IPC: A61K36/88
- IPC: A61K36/88 ; A61K31/05 ; A61K31/11 ; A61K31/7024 ; A61K31/7034 ; A23L33/105 ; A23L29/206 ; A61K9/20 ; A61P25/24 ; A61K9/00
Abstract:
The present invention relates to a powdered composition obtained from saffron stigmas characterized in that it comprises from 0.03% to 1% dry weight of safranal; and at least 3.48% dry weight of crocins that encompasses the various trans-crocin-4 (major isomer), trans-crocin-3, trans-crocin-2′, cis-crocin-4, trans-crocin-2, trans-crocin-1 isomers and any of their mixtures.
Public/Granted literature
- US20190099464A1 SAFFRON EXTRACT AND ITS USE FOR THE PREVENTION OF MOOD DISORDERS RELATED TO DEPRESSION Public/Granted day:2019-04-04
Information query
